Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,477 total articles
AvePoint (AVPT) is a SaaS data-management and governance play positioned to benefit from AI-driven demand for secure collaboration. The balance sheet and free cash flow profile support continued reinvestment while valuation metrics and a sub-$13 entry present a favorable risk/reward for a mid-term trade.
Okeanis Eco Tankers (OET) offers a leveraged way to play continued strength in product tanker spot rates. The company's modern, eco-minded fleet and high utilization give it near-term earnings power that can translate into outsized returns over the next 45 trading days. Initiate a long at $6.00 with a $9.00 target and a $4.50 stop — the setup favor…
Okta's Q1 beat and updated FY27 guide reposition the company as a critical identity platform for the 'agentic' AI era. The stock has already rallied from its April lows, but fundamentals (revenue growth, cash flow) and reasonable enterprise multiples leave room for further upside. This trade recommends entering on a measured pullback and holding th…
Novo Nordisk faces near-term headline risk but the company’s GLP-1 franchise and scalable manufacturing give upside that looks priced for risk. Initiating a buy with an entry at $95.00, stop at $85.00 and primary target of $125.00 over a 180-trading-day horizon.
I previously downgraded Super Micro Computer (SMCI). New evidence on order flow, inventory digestion across the channel, and product mix suggests a higher-probability trade to the long side. This is a tactical swing trade with defined entry, stop and target and a clear set of catalysts and risks.
Spotify is a buy-the-dip swing trade. The company's ambitious 'North Star' goals (1B subscribers, $100B revenue, >40% gross margin by 2030), reasonable current valuation relative to long-term targets, and constructive technicals support a long entry at $470.00, a stop at $435.00, and a target of $650.00 over the next 45 trading days—provided Spotif…
International Petroleum (IPCFF) looks set for a mid-term rebound. The stock trades near $22.46 with a $2.62B market cap, reasonable book multiple and high short interest that can amplify directional moves. This trade idea lays out an actionable entry, stop, targets, catalysts and risk plan for a 45-trading-day swing.
Celldex (CLDX) looks actionable as a 'Strong Buy' into Phase 3 topline for barzolvolimab in chronic spontaneous urticaria (CSU). Phase 2 durable, off-treatment responses, accelerated Phase 3 enrollment and a fresh $345M financing de-risk near-term liquidity and commercial readiness. We lay out an entry, stop, and target tied to the Q4 2026 readouts…
Suncor has executed against operational targets, delivered record upstream volumes and still trades at a valuation that leaves room for mid-term upside. Combine that with a 2.8% yield and manageable leverage and you have a pragmatic long trade with defined risk.
AMD's server stack is now credibly competing with full-rack solutions. Valuation looks rich but the pullback offers an actionable entry for a mid-term trade backed by strong free cash flow, low leverage and concrete customer wins. Trade plan, catalysts and clear stop guidance included.
JD.com looks attractively priced at a $43.7B market cap, trading at a 22.6x PE and 1.51x PB while offering a 3.3% dividend yield. Technicals and short-interest flows show buy-side conviction, and recent strategic moves into AI and logistics strengthen the case for upside to $36.00 over the next 180 trading days. We recommend a long entry at $30.20,…
Riot Platforms is showing technical and fundamental signs that Q2 milestones have shifted the risk/reward in favor of a tactical long. The stock trades near $22.50 with improving momentum, a manageable debt profile, and valuation multiples that reflect growth expectations. This trade idea lays out an entry, stop, target, catalysts, and a balanced r…
DBV Technologies (DBVT) is a clinical-stage immunotherapy play that recently squared up with the FDA around its BLA formatting and sequencing. The market has treated the story as binary and noisy, leaving the stock ~50% off its 52-week high despite positive Phase 3 VITESSE data and a planned BLA submission in Q3 2026. With roughly $190.6M in cash (…
Codexis is an enzyme engineering company whose ECO Synthesis platform has shown reproducible manufacturing gains for siRNA and attracted CDMO validation. A priced public offering at $1.50 that should close on 07/27/2026 adds roughly $23.1M in net proceeds and meaningfully extends runway. Given the operational validation and the immediate capital re…
BETA sits on a roughly $4 billion backlog for hybrid-electric platforms and retrofit solutions. That backlog, combined with a low market capitalization and the prospect of first-commercial deliveries and certification milestones over the next 6-12 months, creates an asymmetric risk-reward for patient traders. This trade idea lays out entry, stop, a…
Allegion (ALLE) just ripped off a short-term run as commercial demand and electronic-lock adoption outpaced residential softness. Fundamentals - including $671M of free cash flow, ROE near 31%, and a sub-1.0 debt/equity ratio - back a constructive view. We lay out a long trade with entry at $153.00, target $180.00 and stop $141.00 for a long-term (…
AST SpaceMobile is on the verge of launching commercial, direct-to-device broadband with carrier partners. The stock has pulled back sharply after a surprise convertible bond and weak macro headlines. For aggressive, event-driven traders willing to tolerate high volatility, a structured long—entry $56.23, stop $45.00, primary target $80.00, stretch…
Coca-Cola Europacific Partners (CCEP) looks like a repeatable earnings compounder. The company sits on a $46.6B market cap, trades at ~22x earnings, yields ~2.2% and is back above key moving averages after a strong recovery from the January low. We argue for a long trade targeting incremental multiple expansion and continued margin recovery, with a…
Alphabet pulled back after an investor update, but core growth vectors - AI cloud, YouTube ad strength and a fortress balance sheet - support a long trade. Enter near $320, protect capital with a $300 stop, and target $380 over the next 180 trading days.
Microsoft is trading well below its 52-week high after a broad tech reset, yet fundamentals remain excellent: $2.84T market cap, $72.9B free cash flow, 30% ROE and a healthy balance sheet. We lay out a long trade with entry, stop and target framed to capture a multi-month recovery toward fair value as AI adoption and cloud growth re-accelerate.
ServiceNow is a high-quality workflow automation leader trading near $98.77 with a $102B market cap, healthy margins and $4.633B in trailing free cash flow. The platform's AI positioning and recent quarterly revenue of $4.0B provide a clear growth runway. I am initiating/additionally layering into a long position with a pragmatic stop and two-stage…
NewAmsterdam Pharma's obicetrapib could rewrite LDL-lowering economics if regulators agree the Phase 3 program delivers meaningful cardiovascular and biomarker outcomes. The stock already prices in successful commercialization to some extent - market cap $3.46B - but upcoming regulatory decisions in H2 2026 and recent positive readouts make NAMS a …
Noah Holdings (NOAH) looks like a high-conviction swing trade: shares are trading near the 52-week low while fundamentals show scale (RMB140.2B AUM), a meaningful dividend event, and a new crypto on/off-ramp partnership. Valuation is attractive (market cap ~$632M, P/B ~0.41, P/E ~8.4). We outline an entry, stop and target for a mid-term trade and t…
Gold Royalty's accelerating royalty cash flow, recent acquisitions and a $100M revolver combine to justify a re-rating from depressed multiples today. The trade: enter $2.57, stop $2.20, target $4.00 over a long-term (180 trading days) horizon. Key risks are gold-price sensitivity, operational execution at partner mines, and potential dilution.
Kimbell Royalty Partners is showing accelerating production and cash flow, a conservative balance sheet, and an attractive yield that now look mispriced versus fundamentals. We upgrade to Buy and outline a clear entry, stop and target for a 45-trading-day swing trade while flagging macro and commodity risks.
